BUCHAN CONSULTING PTY LTD
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Affinity discovers potent SARS-CoV-2 antibodies 2020-07-02 12:25
Alterity Therapeutics meeting with US FDA provides development pathway for ATH434 2020-06-30 11:14
Alterity Therapeutics presents data on ATH434 to the American Academy of Neurology 2020-05-21 08:58
Alterity Therapeutics Limited Releases Its Appendix 4C - Q3 FY20 Quarterly Cash Flow Report 2020-04-30 16:35
Alterity Receives Non-Compliance Notice Regarding NASDAQ Minimum Bid Price Requirement 2020-02-07 21:00
"Live bacteria" soil health and animal nutrition firm Terragen Holdings Ltd launches $20m IPO 2019-11-05 06:10
Admedus Inks $A36.2M Deal for CardioCel And VascuCel Patch Business 2019-10-14 12:51
1 2 3 4